The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Ubigene Biosciences
New York, United States
B
51-100 Employees
-
Key takeaway
Ubigene is dedicated to making genome editing easier, offering advanced gene-editing services and products. Their innovative CRISPR-U™ technology significantly enhances gene-editing efficiency, and they provide a comprehensive automated design system that supports researchers in this field.
Reference
Service
| Ubigene
Axolabs
Kulmbach, Germany
A
11-50 Employees
2007
Key takeaway
Axolabs is a leading service provider specializing in the discovery, development, and manufacture of therapeutics based on DNA or RNA, with over 20 years of expertise in oligonucleotide research. Their integrated solutions encompass all stages of research and development, ensuring high-quality services and products for the successful development of nucleic acid-based therapeutics, including gene editing.
Reference
Service
Gene Editing / Axolabs
TargetGene Biotechnologies
Rishon LeZion, Israel
B
1-10 Employees
2012
Key takeaway
TargetGene has developed a leading genome editing platform and is now prepared to collaborate in the therapeutics sector, highlighting its commitment to advancing cures through innovative gene editing technologies.
Reference
Core business
TARGETGENE – DEVELOPING THE WORLD’S BEST THERAPEUTIC GENOME EDITING PLATFORM
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Inscripta
Boulder, United States
B
101-250 Employees
2015
Key takeaway
The company highlights its innovative approach to gene editing through methods like CRISPR and Directed Evolution, which enhance biomanufacturing and enable the discovery of beneficial genetic changes. Their digital genome engineering tools promise to transform various fields, including material production, agriculture, and disease treatment.
Reference
Product
Genome Editing - Inscripta®
Our revolutionary digital genome engineering tools transform how we face complex global challenges and yield solutions that benefit all.
Scribe Therapeutics
United States
B
11-50 Employees
2017
Key takeaway
The company is focused on advancing gene editing through innovative delivery technologies that enhance in vivo genetic medicine. Their approach emphasizes precision targeting within the genome, which is essential for developing effective therapies.
Reference
Core business
Scribe
Editas Medicine
Cambridge, United States
B
101-250 Employees
2013
Key takeaway
Editas Medicine is at the forefront of gene editing, utilizing CRISPR technology to develop innovative genomic medicines aimed at transforming the lives of individuals with serious diseases. They are actively researching both in vivo and ex vivo gene editing approaches to create effective treatments that target genetic disorders.
Reference
Core business
Editas Medicine
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Edilytics
Cambridge, United States
B
1-10 Employees
2019
Key takeaway
Edilytics offers advanced precision genome editing solutions, highlighting CRISPResso2 as a trusted tool for analyzing gene editing experiments. This platform provides comprehensive data and user-friendly features, making it suitable for both academia and industry.
Reference
Core business
Edilytics | Precision Genome Editing Analysis
Metagenomi
Emeryville, United States
B
51-100 Employees
2018
Key takeaway
Metagenomi is developing potentially curative therapeutics through its metagenomics-powered gene editing toolbox, which utilizes undiscovered genetic material from natural environments. Their approach aims to create innovative genetic medicines by matching optimal gene editing tools to specific medical indications.
Reference
Core business
Curative Gene Editing Forged From Nature | Metagenomi
Metagenomi is transforming novel gene editing tools, mined from the world’s natural microbial environment, into life-saving genetic medicines.
CRISPR AgroBio News (CARBON)
Copenhagen, Denmark
A
1-10 Employees
2022
Key takeaway
Biomedrex Genetics is dedicated to advancing innovation in gene therapy and genome editing, specifically highlighting the use of CRISPR and other gene editing tools. Their focus includes delivering comprehensive information on the latest developments, safety, and clinical applications in the field.
Reference
Core business
Company: Biomedrex Genetics
More than 100 companies to follow in 2023 working with a gene editing tool like CRISPR, TALEN, ZFN, Prime Editor, Base Editor, MegaNuclease...
COBO Technologies - Quality Control Genome Editing
Copenhagen, Denmark
A
1-10 Employees
2017
Key takeaway
COBO Technologies is a specialized company focused on quality control for CRISPR-modified cells and animals, emphasizing their expertise in gene editing and therapy. Their extensive use of the INDEL Profiling Platform and the publication record of their expert Eric highlight their commitment to advancing targeted gene editing technologies.
Reference
Core business
COBO Technologies - Quality Control Genome Editing
COBO Technologies specialised in products and services for Quality Control of CRISPR modified cells/animals. DNA mutation analysis and Protein Expression profiling
Technologies which have been searched by others and may be interesting for you:
Gene editing is a revolutionary biotechnology that allows scientists to alter an organism's DNA with precision. This process involves making specific changes to the genetic material, which can lead to modifications in traits or characteristics of living organisms. Techniques such as CRISPR-Cas9 have made gene editing more accessible, enabling researchers to edit genes effectively in various species, including plants, animals, and humans. By targeting specific sequences in the genome, gene editing can be used for a wide range of applications, from improving crop resilience to treating genetic disorders in humans. The ability to edit genes holds great promise for advancements in medicine, agriculture, and environmental stewardship, as it opens the door to innovative solutions for some of the world's most pressing challenges.
Gene editing involves making precise alterations to an organism's DNA, allowing scientists to modify genes at specific locations. This technology operates using various methods, with CRISPR-Cas9 being the most prominent. In this technique, a guide RNA directs the Cas9 enzyme to the target DNA sequence, where it creates a double-strand break. The cell's natural repair mechanisms then kick in, which can either introduce changes to the genetic material or allow for the insertion of new genetic information. Another approach is using zinc finger nucleases (ZFNs) or transcription activator-like effector nucleases (TALENs), both of which also facilitate targeted cuts in DNA. These methods enable researchers to knock out genes, correct mutations, or introduce new traits by providing a template for the repair process. The precision and efficiency of gene editing have made it a revolutionary tool in genetics, with applications spanning agriculture, medicine, and biotechnology.
1. Medicine
Gene editing holds significant potential in medicine, particularly for treating genetic disorders. Conditions such as cystic fibrosis and sickle cell anemia may be addressed by directly modifying the faulty genes responsible for these diseases. This technology allows for precise alterations that can correct mutations, leading to long-term health improvements.
2. Agriculture
In agriculture, gene editing can enhance crop resilience and yield. By modifying specific genes, plants can be made more resistant to pests, diseases, and environmental stressors. This not only improves food security but also reduces the need for chemical pesticides, promoting a more sustainable approach to farming.
3. Biotechnology
The biotechnology sector benefits from gene editing in developing biofuels and biopharmaceuticals. By engineering microorganisms to produce specific compounds more efficiently, gene editing can streamline production processes and reduce costs. This innovation supports advancements in renewable energy and healthcare solutions.
Ethical considerations surrounding gene editing are multifaceted and complex. One significant concern is the potential for unintended consequences, as altering genes could lead to unforeseen health issues in individuals and subsequent generations. This raises questions about the long-term impacts on human evolution and biodiversity. Another critical aspect is the issue of consent, particularly when it involves editing the genes of embryos or germline cells, as these decisions are made without the individual's ability to consent. The risk of creating inequalities in access to gene editing technologies also poses ethical dilemmas. Wealthier individuals may have more opportunities to enhance their genetic traits, leading to social divides. Furthermore, there are debates about the morality of "designer babies," where gene editing could be used to select traits, potentially shifting societal norms around what is considered desirable.
Gene editing carries several risks that can have significant implications. One major concern is the potential for unintended genetic modifications, which may lead to harmful effects or genetic disorders in the edited organism. These off-target effects can occur if the editing tools, like CRISPR, mistakenly alter genes that were not intended to be modified. Furthermore, ethical considerations arise regarding the manipulation of genetic material. There is a risk of creating genetic inequities, where access to gene editing technologies could be limited to certain populations. This could lead to social divides and issues surrounding consent, particularly in cases involving human embryos or germline editing. The long-term consequences of gene editing on ecosystems and biodiversity also raise concerns, as releasing genetically modified organisms into the wild could disrupt natural balances.
Some interesting numbers and facts about your company results for Gene Editing
Country with most fitting companies | United States |
Amount of fitting manufacturers | 10000 |
Amount of suitable service providers | 8844 |
Average amount of employees | 11-50 |
Oldest suiting company | 2007 |
Youngest suiting company | 2022 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Gene Editing
What are related technologies to Gene Editing?
Based on our calculations related technologies to Gene Editing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Gene Editing?
Start-Ups who are working in Gene Editing are CRISPR AgroBio News (CARBON)
Which industries are mostly working on Gene Editing?
The most represented industries which are working in Gene Editing are IT, Software and Services, Biotechnology, Other, Healthcare, Medical
How does ensun find these Gene Editing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.